Pastāsti draugiem par šo preci:
Simultaneous Estimation of Aliskiren and Valsartan by Using Hplc L. Kalyani
Pasūtīts no attālās noliktavas
Mūsu klienti saka:
Simultaneous Estimation of Aliskiren and Valsartan by Using Hplc
L. Kalyani
This work is aimed to develop a simple, precise and accurate HPLC method for the assay of Aliskiren and Valsartan. Aliskiren hemifumarate is a direct renin inhibitor and is indicated for essential hypertension. Valsartan is a nonpeptide specific angiotensin II receptor blocker and is indicated for the treatment of hypertension. The combination of Aliskiren and Valsartan is indicated for the treatment of hypertension. Hence the objective of this research work is to develop and validate a HPLC method for the simultaneous estimation of Aliskiren and Valsartan in bulk drug and pharmaceutical dosage forms as per ICH guidelines. Various trials were carried out for the optimization of the HPLC method for simultaneous estimation of Aliskiren and Valsartan.
| Mediji | Grāmatas Paperback Book (Grāmata ar mīksto vāku un līmēto muguru) |
| Izlaists | 2014. gada 14. marts |
| ISBN13 | 9783659157332 |
| Izdevēji | LAP LAMBERT Academic Publishing |
| Lapas | 56 |
| Izmēri | 150 × 3 × 226 mm · 102 g |
| Valoda | Vācu |
Skatīt visus L. Kalyani